Consumer satisfaction with opioid treatment services at community pharmacies in Australia.
OBJECTIVE
To explore consumer satisfaction with, and experiences of, a range of issues associated with the delivery of opioid substitution treatment at community pharmacies in New South Wales, Australia.


METHODS
50 community pharmacies providing opioid substitution treatment in New South Wales.


METHODS
Self-completion survey completed by 508 clients during supervised dosing.


METHODS
Satisfaction with opioid substitution treatment delivery at community pharmacies.


RESULTS
Sixty-one percent of participants reported being satisfied with their treatment programme. Participants expressed a high level of satisfaction with most aspects of opioid substitution treatment delivery at their pharmacy (aggregate mean = 8.1/10; 10 = excellent). However, participants were less satisfied with the level of privacy afforded at the pharmacy. Thirty-four percent reported that they were made to wait longer than other customers, and 25% reported that the pharmacy staff did not treat them the same as other customers. However, 87% reported that they felt welcomed by the pharmacy staff. Twenty-three percent of clients were currently in debt to the pharmacy for nonpayment of dispensing fees. The mean amount of current debt was $71.75, equivalent to approximately 2 weeks of pharmacy dispensing fees.


CONCLUSIONS
Community pharmacies providing opioid substitution treatment in New South Wales appear to be providing a level of service that is satisfactory to the clients of those services. However, many participants were concerned about a lack of privacy, the high cost of treatment, and being treated differently to other customers.
Lea
Toby
T
Sydney South West Area Health Service, Sydney, Australia. toby.lea@sswahs.nsw.gov.au
Sheridan
Janie
J
Winstock
Adam
A
D000328:Adult; D001315:Australia; D003157:Community Pharmacy Services / Q000191:economics / Q000592:standards*; D023801:Directly Observed Therapy; D016527:Drug Costs; D005260:Female; D005382:Financing, Personal; D006801:Humans; D008297:Male; D008875:Middle Aged; D009294:Narcotics / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D009517:New South Wales; D009293:Opioid-Related Disorders / Q000188:drug therapy* / Q000191:economics / Q000534:rehabilitation; D017060:Patient Satisfaction; D018907:Privacy / Q000523:psychology; D011795:Surveys and Questionnaires
D009294:Narcotics